The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Karyopharm Therapeutics Inc(NASDAQ:KPTI) 
Karyopharm Therapeutics Inc., a pharmaceutical company, engages in the discovery, development, and commercialization of various drugs directed against nuclear export and related targets for the treatment of cancer and other diseases. The company is developing small molecule selective inhibitor of nu...
Website: http://www.karyopharm.com
Founded: 2008
Full Time Employees: 347
Sector: Healthcare
Industry: Biotechnology
Karyopharm Therapeutics Days Payable Outstanding ttm (DPO)
Karyopharm Therapeutics Days Receivable Outstanding ttm (DSO)
Karyopharm Therapeutics Days Inventory Outstanding ttm (DIO)
Karyopharm Therapeutics Op Cashflow Per Share ttm
Karyopharm Therapeutics Free Cashflow Per Share ttm
Karyopharm Therapeutics Cash Per Share ttm
Karyopharm Therapeutics P/S ratio ttm
Karyopharm Therapeutics (GAAP) P/E ratio ttm
Karyopharm Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.